Western Wealth Management LLC Has $629,000 Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Western Wealth Management LLC lessened its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 73.5% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,205 shares of the medical equipment provider's stock after selling 3,334 shares during the period. Western Wealth Management LLC's holdings in Intuitive Surgical were worth $629,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of ISRG. Atala Financial Inc purchased a new position in shares of Intuitive Surgical in the 4th quarter valued at $25,000. Berbice Capital Management LLC acquired a new stake in Intuitive Surgical in the fourth quarter valued at about $26,000. Parvin Asset Management LLC purchased a new position in Intuitive Surgical in the fourth quarter worth $26,000. BankPlus Trust Department purchased a new stake in shares of Intuitive Surgical during the 4th quarter worth approximately $28,000. Finally, Hurley Capital LLC acquired a new position in shares of Intuitive Surgical during the 4th quarter worth $28,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Price Performance

Shares of ISRG stock traded up $3.77 during trading hours on Thursday, reaching $556.18. The stock had a trading volume of 364,296 shares, compared to its average volume of 1,640,392. Intuitive Surgical, Inc. has a twelve month low of $396.15 and a twelve month high of $616.00. The firm has a 50-day simple moving average of $514.87 and a 200-day simple moving average of $538.30. The firm has a market capitalization of $199.34 billion, a PE ratio of 86.70, a price-to-earnings-growth ratio of 5.85 and a beta of 1.70.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. The company had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same quarter in the previous year, the business earned $1.50 EPS. On average, equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analysts Set New Price Targets

Several analysts have recently issued reports on ISRG shares. BTIG Research set a $560.00 price objective on Intuitive Surgical and gave the company a "buy" rating in a research report on Monday, April 14th. Truist Financial lowered their price target on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating for the company in a report on Wednesday, April 23rd. Barclays decreased their target price on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a research report on Thursday, April 24th. Robert W. Baird cut their price target on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. Finally, Piper Sandler dropped their target price on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a research note on Wednesday, April 23rd. Five analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical currently has a consensus rating of "Moderate Buy" and an average target price of $596.05.

Insider Transactions at Intuitive Surgical

In related news, SVP Mark Brosius sold 492 shares of Intuitive Surgical stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $573.78, for a total value of $282,299.76. Following the completion of the sale, the senior vice president now owns 4,056 shares of the company's stock, valued at approximately $2,327,251.68. The trade was a 10.82% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Robert Desantis sold 11,545 shares of the stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the transaction, the executive vice president now directly owns 5,224 shares in the company, valued at approximately $2,607,925.28. This represents a 68.85% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 30,299 shares of company stock valued at $15,470,640 over the last three months. Company insiders own 0.70% of the company's stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.